XML 73 R41.htm IDEA: XBRL DOCUMENT v3.25.2
Fair Value of Financial Instruments (Tables)
12 Months Ended
Jun. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair value
The following table summarizes the valuation of the Company's remaining assets and liabilities measured at fair value on a recurring basis as of June 30, 2025:
TotalQuoted
prices in
active
markets
(Level 1)
Significant
other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
(in thousands)
Assets:
Deferred compensation plan investments, current and non-current portion$31,887 $31,887 $ $ 
Forward foreign currency exchange contracts15  15  
Interest rate swap agreement680  680  
Total assets at fair value$32,582 $31,887 $695 $ 
Liabilities:
Deferred compensation plan investments, current and non-current portion$31,887 $31,887 $ $ 
Foreign currency hedge290  290 — 
Liability for contingent consideration, current and non-current19,100   19,100 
Total liabilities at fair value$51,277 $31,887 $290 $19,100 

The following table presents assets and liabilities measured at fair value on a recurring basis as of June 30, 2024:

TotalQuoted
prices  in
active
markets
(Level  1)
Significant
other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
(in thousands)
Assets:
Deferred compensation plan investments, current and non-current portion$31,014 $31,014 $— $— 
Interest rate swap agreement2,698 — 2,698 — 
Foreign currency hedge345 — $345 — 
Total assets at fair value$34,057 $31,014 $3,043 $— 
Liabilities:
Deferred compensation plan investments, current and non-current portion$31,014 $31,014 $— $— 
Forward foreign currency exchange contracts12 — 12 — 
Total liabilities at fair value$31,026 $31,014 $12 $— 
Schedule of Changes in Fair Value of Contingent Considerations
The following tables represent the Company's contingent consideration liabilities at fair value at June 30, 2025:
Fiscal Year Ended June 30, 2025
Specialty Technology SolutionsIntelisys & AdvisoryTotal
(in thousands)
Fair value at beginning of period$ $ $ 
Issuance of contingent consideration7,500 9,700 17,200 
Change in valuation(840)2,740 1,900 
Fair value at end of period$6,660 $12,440 $19,100 
Valuation techniques and significant observable inputs used in recurring Level 3 fair value measurements for the Company's contingent consideration liabilities related to Advantix and Resourcive at June 30, 2025 were as follows.
AcquisitionReporting PeriodValuation TechniqueSignificant Unobservable InputsAverage Rates
AdvantixJune 30, 2025Discounted cash flowAdjusted EBITDA risk premium15.3 %
Adjusted EBITDA growth rate31.8 %
ResourciveJune 30, 2025Monte CarloAdjusted EBITDA risk premium12.7 %
Simulated commission growth percentage24.2 %